Zobrazeno 1 - 10
of 542
pro vyhledávání: '"S, Pawelski"'
Autor:
Jillian A Bristol, Scott E Nelson, Makoto Ohashi, Alejandro Casco, Mitchell Hayes, Erik A Ranheim, Abigail S Pawelski, Deo R Singh, Daniel J Hodson, Eric C Johannsen, Shannon C Kenney
Publikováno v:
PLoS Pathogens, Vol 20, Iss 4, p e1012132 (2024)
Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent forms of viral latency that do not express either of the two major EBV oncoproteins, EBNA2
Externí odkaz:
https://doaj.org/article/43ac485e6f8547838097af8a167f2b00
Autor:
Deo R Singh, Scott E Nelson, Abigail S Pawelski, Juan A Cantres-Velez, Alisha S Kansra, Nicholas P Pauly, Jillian A Bristol, Mitchell Hayes, Makoto Ohashi, Alejandro Casco, Denis Lee, Stuart A Fogarty, Paul F Lambert, Eric C Johannsen, Shannon C Kenney
Publikováno v:
PLoS Pathogens, Vol 18, Iss 10, p e1010868 (2022)
Differentiated epithelial cells are an important source of infectious EBV virions in human saliva, and latent Epstein-Barr virus (EBV) infection is strongly associated with the epithelial cell tumor, nasopharyngeal carcinoma (NPC). However, it has be
Externí odkaz:
https://doaj.org/article/c603bab0a33b48b1a46a9dd7f2ea5c12
Autor:
Deo R. Singh, Scott E. Nelson, Abigail S. Pawelski, Alisha S. Kansra, Stuart A. Fogarty, Jillian A. Bristol, Makoto Ohashi, Eric C. Johannsen, Shannon C. Kenney
Publikováno v:
Proceedings of the National Academy of Sciences. 120
Latent Epstein–Barr virus (EBV) infection promotes undifferentiated nasopharyngeal carcinomas (NPCs) in humans, but the mechanism(s) for this effect has been difficult to study because EBV cannot transform normal epithelial cells in vitro and the E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb62ab0adedf9253cdbe456d6f0eee3b
https://doi.org/10.1073/pnas.2219755120
https://doi.org/10.1073/pnas.2219755120
Autor:
S, Pawelski
Publikováno v:
Acta haematologica Polonica. 26(3)
Fludarabine, an analogue of arabinosyl adenine, used since 1986 proved to be a new agent effective particularly in chronic lymphocytic leukaemia. About 35% of patients refractory to previous cytostatic treatment and about 75% of untreated patients ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8de8433f5e2bbd00822883a7dd578551
https://pubmed.ncbi.nlm.nih.gov/8525771
https://pubmed.ncbi.nlm.nih.gov/8525771
Autor:
S, Pawelski
Publikováno v:
Acta haematologica Polonica. 26(2)
In the last years a great progress was observed in the treatment of hairy cell leukaemia due to the introduction of interferon-alfa, pentostatin and above all -2-CdA. Through the programmed death - apoptosis of the hairy lymphocytes 2-CdA causes afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0875f60add7186caa7593c7b3182e3f
https://pubmed.ncbi.nlm.nih.gov/7653218
https://pubmed.ncbi.nlm.nih.gov/7653218
Autor:
S, Pawelski
Publikováno v:
Acta haematologica Polonica. 24(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16ef1d0d193735a2000d493bcb7aacfe
https://pubmed.ncbi.nlm.nih.gov/8488737
https://pubmed.ncbi.nlm.nih.gov/8488737
Publikováno v:
Leukemias ISBN: 9783642770852
Anthracycline antibiotics used in combination with other agents can produce complete remission (CR) in about 70%–80% previously untreated and possibly selected group of patients with acute nonlymphoblastic leukemia (ANLL) [2,3].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17880a194b7cb9be56ab2486e6925ed2
https://doi.org/10.1007/978-3-642-77083-8_44
https://doi.org/10.1007/978-3-642-77083-8_44
Publikováno v:
Leukemias ISBN: 9783642770852
Since 1865 the basic treatment of chronic myeloid leukemia (CML) has been chemotherapy: arsenic, urethan, busulphan and other alkylating agents, hydroxyurea and only recently, radiotherapy of the spleen or use of radioactive [32P] phosphate. The most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::683062e9da617c23de97970abd2a0b42
https://doi.org/10.1007/978-3-642-77083-8_45
https://doi.org/10.1007/978-3-642-77083-8_45
Autor:
E. Rudzka, J. Holowiecki, Jerzy Wojnar, G. Palynyczko, S. Krzemien, ł Kachel, S. Pawelski, R. Konecki, L. Konopka, J. Mazur, T. Rozmyslowicz, T. Ławniczek, S. Maj, Apel D, B. Mariańska
Publikováno v:
Acute Leukemias ISBN: 9783540539490
In the last few years several new agents for the treatment of acute leukemia have been studied. These have included amsacrine, idarubicin, mitoxantrone, homoharringtonine and most recently diaziquone [1]. Mitoxantrone is a relatively new synthetic an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40897f2aaa1381985efc18cbb1c08494
https://doi.org/10.1007/978-3-642-76591-9_72
https://doi.org/10.1007/978-3-642-76591-9_72